Industry Warns FDA Not to Prohibit DTC; Agency Considering New Rules

Drug Industry Daily
KEYWORDS Advertising / FDA
A A

Pharmaceutical companies are ready to legally challenge any efforts to eliminate direct-to-consumer (DTC) advertising, industry officials said during the first day of a two-day FDA public hearing on DTC activities. Agency officials responded that they will not seek to prohibit DTC ads, but are considering new ways to regulate the practice.

To View This Article:

Login

Subscribe To Drug Industry Daily